Treatment with tirzepatide demonstrated a 38% decrease in the risk of heart failure outcomes (composite endpoint) compared with placebo. Detailed results were announced from the phase 3 SUMMIT trial ...

ALL Study Groups using DehydraTECH Processing Outperform Rybelsus in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study ...

- DehydraTECH-liraglutide and a select DehydraTECH-CBD formulation were the top performing groups in the Study outperforming the Rybelsus® control group in both body weight-loss, by 11.53% and 10.65% ...

Doctors say GLP-1s are not approved as a prevention method for menopause weight gain. Here's how to manage the weight changes ...

Novo Nordisk stock has been pretty volatile lately, making it hard to judge whether now is a good opportunity to buy shares.

LOTTIE Moss has revealed how her Ozempic hospital dash and terrifying seizure changed her life, while admitting she’d “never ...

Over 137 million US adults are eligible for semaglutide, driven by expanding indications for diabetes, weight management, and ...

A study found that GLP-1 RA use is linked to risks for retained gastric contents during single endoscopic procedures but not ...

Glucagon-like peptide-1 receptor agonists are FDA-approved medications that mimic the action of a naturally occurring hormone ...

The fund posted returns of 6.75% (Institutional shares) and 6.68%(Investor A shares, without sales charge) for the third ...

By Dr. Sushama R. Chaphalkar, PhD. Research shows how common diabetes medications are transforming asthma care by reducing ...